SHENZHEN, China, July 16, 2025 -- Huawei held the 2025 Global Education and Healthcare Partner China Convention. Over 300 partner guests from 40 countries attended. At the event, Huawei launched the Global Education and Healthcare Partner Alliance (GEHPA). This initiative aims to strengthen communication with industry partners, leverage mutual strengths, achieve win-win cooperation, and ultimately build a high-quality, sustainable industry ecosystem. Members of the alliance can jointly undertake technical research and develop innovative solutions to power the digital transformation of educati
[ 메디채널 김갑성 기자 ] Best ESG rating tier of negligible-risk with a top 1% global ranking score Industry and Regional ESG Top-Rated Company for five consecutive years Leader in Green CRDMO to drive innovation for a healthier future SHANGHAI, July 16, 2025 -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has elevated its Morningstar Sustainalytics ESG rating score to the highest negligible-risk tier, demonstrating its leadership in the global pharmaceutical industry. Sustainalytics is a lea
SHENZHEN, China, July 16, 2025 -- Huawei held the 2025 Global Education and Healthcare Partner China Convention. Over 300 partner guests from 40 countries attended. At the event, Huawei launched the Global Education and Healthcare Partner Alliance (GEHPA). This initiative aims to strengthen communication with industry partners, leverage mutual strengths, achieve win-win cooperation, and ultimately build a high-quality, sustainable industry ecosystem. Members of the alliance can jointly undertake technical research and develop innovative solutions to power the digital transformation of educati
Photos: https://drive.google.com/drive/folders/1OIKkIC7kIPhFq-FWR7pO1-JbERqg29mN?usp=sharing HONG KONG, July 16, 2025 -- With shells drawing near and only minutes to escape, what would you save? "I was forced to leave everything behind – my toys, my clothes, all the things I loved," said 8-year-old Syrian girl Amal. In the harsh winter of 2024, she and her family walked for two days to flee the conflict, carrying nothing but the thin clothes on their backs. Food, water, shelter, and even a sense of security were all unwillingly left behind. A Tent for a Home
KUALA LUMPUR, Malaysia, July 16, 2025 -- A regional effort to improve cervical cancer care for patients has launched in Malaysia. Involving 6 countries in Southeast Asia, Project ACTIVE 2.0 aims to enhance cervical cancer treatment and support patient recovery across Southeast Asia. The three-year initiative will focus on strengthening healthcare systems through clinical training, infrastructure upgrades, and digital innovations, with the goal of expanding access to high-quality, targeted cervical cancer care for patients and their families. Cervical cancer remains a significan
Study shows sustained improvements in heart failure symptoms and function following long-term C-MIC therapy ZUG, Switzerland, July 16, 2025 -- Berlin Heals, a pioneer in bioelectric medicine for the treatment of heart failure, is pleased to announce the publication of a new peer-reviewed study titled "Two-year outcomes of a cardiac microcurrent device in chronic heart failure: A first-in-human pilot study" in the ESC Heart Failure journal. The study presents the long-term follow-up of patients enrolled in the initial pilot trial of the Cardiac Microcurrent I
[ 메디채널 김갑성 기자 ] - AI Medical Service Inc. from Japan Wins Gold Prize - TOKYO, July 16, 2025 -- During the "Health and Well-being" theme week at the Expo 2025 Osaka, Kansai, the Japan External Trade Organization (JETRO) and Japan's Ministry of Economy, Trade and Industry (METI) jointly hosted an international symposium on healthcare and a pitch competition for healthcare startups from around the world, titled the "Global Healthcare Challenge" (GHeC), at the Grand Prince Hotel Osaka Bay on June 25 (Wednesday) and 26 (Thursday), 2025. The event was designed to help J
TAIPEI and SAN DIEGO, July 16, 2025 -- Senhwa Biosciences, Inc. (TPEx: 6492), a new drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announced that its new drug Pidnarulex (CX-5461) has been selected by the U.S. National Cancer Institute (NCI) as part of a five-year cancer research program. The first patient in the monotherapy clinical trial for advanced solid tumors has been successfully enrolled at the NIH Clinical Center in Bethesda, Maryland, USA. The NCI will fund the full cost of the
MANILA, Philippines, July 16, 2025 -- Medley (TSE: 4480), a leading Japan-based healthcare technology group, has announced the relocation and expansion of its operational functions in the Philippines to help accelerate the company's global business growth. The new office, located at 32nd Street corner 3rd Avenue, Bonifacio Global City (BGC), Taguig City, offers a sleek, modern space for the company's fast-growing team. It will serve as a key operational hub for Medley's global business and underscores the company's continued commitment to international expansion. Remaining in
TOKYO, July 16, 2025 -- Fujitsu Limited and Acer Medical Inc., a provider of AI-powered medical imaging and preventative medicine, today announced a collaborative agreement to develop "aiGait" powered by Uvance, a solution that leverages Fujitsu's advanced skeleton recognition AI technology to detect gait pattern abnormalities, and provide gait quantization to healthcare professionals to support the early diagnosis of dementia and Parkinson's disease. The technology is part of "Fujitsu Kozuchi for Vision" from the Fujitsu Uvance offering "AI Technologies and Solutions